Adrian Coogan

Adrian Coogan is an experienced pharmaceutical professional currently serving as Associate Director of Drug Substance Development at Jazz Pharmaceuticals since January 2022. Prior experience includes roles at Ipsen, where Adrian held positions as Principal Chemist and Senior API Development Specialist, leading external development projects for small molecule APIs in oncology and rare diseases. Adrian's career includes significant contributions at Bristol-Myers Squibb as a Manufacturing Science and Technology PhD Chemist, and a PhD research role at Trinity College Dublin focusing on tubulin-binding agents. Adrian holds a Doctor of Philosophy in Medicinal and Pharmaceutical Chemistry and has a comprehensive background in process development, scale-up, and quality assurance, supported by proficiency in Lean principles and various analytical techniques.